Hidrospot (Hydroquinone)

Hidrospot is used to lighten areas of hyperpigmentation on the skin.

• Treatment of melasma, a chronic facial pigmentation disorder.
• Reduction of age spots (lentigines) and solar lentigines.
• Lightening of post‑inflammatory hyperpigmentation following skin injury.
• Management of freckles and other localized pigment irregularities.
• Adjunct therapy for cosmetic improvement of uneven skin tone.

• Hydroquinone works by inhibiting the enzyme tyrosinase, which is essential for the conversion of the amino acid tyrosine to melanin within melanocytes. By blocking this enzymatic step, the drug reduces the synthesis of melanin pigment, leading to a gradual lightening of existing hyperpigmented lesions and preventing the formation of new pigment deposits. The inhibition is dose‑dependent and results in decreased melanosome formation within the cells, contributing to a visible reduction in skin darkness over several weeks of consistent use.

Topical hydroquinone may cause local skin reactions, most of which are mild and reversible.

Common

• Mild redness or erythema at the application site.
• Slight itching or burning sensation.
• Dryness or peeling of the treated skin.
• Temporary darkening of the pigment (post‑inflammatory hyperpigmentation).
• Mild swelling or edema.

Serious

• Allergic contact dermatitis with intense itching, rash, or vesicles.
• Ochronosis, a bluish‑gray discoloration of the skin from prolonged use.
• Severe irritation leading to ulceration or infection.
• Unexpected widespread depigmentation (vitiligo‑like changes).
• Persistent skin discoloration after discontinuation.

Before using Hidrospot, consider the following precautions to minimize risks and ensure safe application.

• Perform a patch test on a small skin area for at least 24 hours before full‑area use.
• Avoid application on broken, inflamed, or infected skin.
• Limit use to the prescribed area and do not exceed the recommended duration, typically no longer than 12 weeks without medical supervision.
• Protect treated skin from excessive sun exposure; use broad‑spectrum sunscreen with SPF 30 or higher.
• Discontinue use if severe irritation, rash, or unexpected discoloration occurs.
• Pregnant or breastfeeding individuals should consult a healthcare professional before use.

Hydroquinone can interact with certain topical agents and systemic substances; be aware of the following.

Avoid

• Concurrent use of other strong bleaching agents such as tretinoin, corticosteroids, or azelaic acid without medical guidance.
• Application of chemical peels, laser therapy, or microdermabrasion on the same area during treatment.
• Use of products containing mercury or other heavy metals that may exacerbate skin irritation.

Use with caution

• Combining hydroquinone with retinoids may increase irritation; monitor skin response closely.
• Use of photosensitizing drugs (e.g., tetracyclines) may heighten sun sensitivity; employ diligent photoprotection.
• Concurrent systemic antioxidant supplements (vitamin C, E) are generally safe but should be discussed with a clinician.